I think what you're seeing is the realization that AMRN is likely dead money in 2021 (with BO likely off table) and there are a lot of other opportunities out there after the market sell off. US scripts aren't moving, generics are stealing market share, are there more generics on the way? No meaningful EU sales in 2021.....and EU approval is already known. After the US sales execution, does anyone have confidence in the EU execution? I don't.
The other items are Hail Mary's. We're now a Hail Mary binary event driven stock. Fun!
News 
Market Data 
Discover 
